The main problem for playing the anti-tumor role of XCL1+ CD8+ T cells is the low expression of XCL1 and key related genes (XCR1 and XCL2) in tumor microenvironment of HCC. This evidence concerns the gene XCR1 and hepatocellular carcinoma.